DarioHealth
DRIO
60 hedge funds and large institutions have $101M invested in DarioHealth in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 6 closing their positions.
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
5% more funds holding
Funds holding: 57 → 60 (+3)
2% more capital invested
Capital invested by funds: $98.2M → $101M (+$2.37M)
0.16% more ownership
Funds ownership: 2.18% → 2.34% (+0.16%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
40% less call options, than puts
Call options by funds: $970K | Put options by funds: $1.62M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$5.29M |
| 2 |
AWAM
Appian Way Asset Management
New York
|
+$4.48M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.07M |
| 4 |
BlackRock
New York
|
+$887K |
| 5 |
CHM
Collaborative Holdings Management
New York
|
+$608K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$911K |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$898K |
| 3 |
MS
Maven Securities
St Helier,
Jersey
|
-$887K |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$752K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$549K |
DRIO Hedge Fund Activity: Q4 2021 in Review
60 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2021, worth a combined $101M — up 2.4% from $98.2M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new DRIO positions and 6 closed out — a net gain of 3 holders — while 18 added to existing stakes and 18 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $5.29M. The largest seller was GSA Capital Partners, exiting entirely with an estimated $911K sold.
- 60 institutional investors held DarioHealth (DRIO) as of Q4 2021, up from 57 in Q3 2021.
- Funds reported $101M of DarioHealth stock for Q4 2021, up 2.4% quarter-over-quarter.
- 9 funds opened new DarioHealth positions in Q4 2021 and 6 closed out, a net change of +3 holders.
- The largest DarioHealth buyer in Q4 2021 was Nantahala Capital Management, an estimated $5.29M added.
- The largest DarioHealth seller in Q4 2021 was GSA Capital Partners, an estimated $911K sold.
Based on aggregated 13F filings for Q4 2021.